Home / Companies / Wallac Oy, Subsidiary of Perkinelmer

Wallac Oy, Subsidiary of Perkinelmer

FDA Regulatory Profile

Wallac Oy, Subsidiary of Perkinelmer appears in FDA public data with 0 recalls, 2 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on September 4, 2018.

Summary

Total Recalls
0
510(k) Clearances
2
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K173568NeoBase 2 Non-derivatized MSMS KitSeptember 4, 2018
K102419GSP NEONATAL IRT KIT (3306-001U)December 16, 2010

FDA data resources